Prostate Cancer Clinical Trials in Ventura, CA

Prostate Cancer Clinical Trials in Ventura, CA

View the best 10 prostate cancer medical studies in Ventura, California. Access promising new therapies by applying to a Ventura-based Prostate Cancer clinical trial.

Trials in Ventura, California

Here are the top 10 medical studies for prostate cancer in Ventura, California

Image of Nebraska Cancer Specialists in Omaha, United States.

177Lu-PSMA-617 +2 More

Radioisotope Therapy

Recruiting2 awardsPhase 3
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Image of Yale Cancer Center in New Haven, United States.

Radical Prostatectomy +1 More

Procedure

Recruiting1 award6 criteria
This trial compares a new treatment with traditional surgery in men with prostate cancer. The goal is to see if the new treatment can effectively treat cancer while preserving important functions better than surgery. Patients will be followed for several years to assess outcomes. The new treatment is minimally invasive and uses advanced technology to target prostate tissue.
Image of Research Site in Lakewood, United States.

Docetaxel +1 More

Taxane

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Image of NCT01946204 in Birmingham, United States.

Apalutamide

Antiandrogen

Recruiting1 awardPhase 3
This trial will test whether apalutamide can help treat prostate cancer that is not responding to hormone therapy and has not spread.
Image of University of California San Francisco in San Francisco, United States.

Lutetium Lu 177-PSMA-617

Radioisotope Therapy

Recruiting1 awardPhase 2
"This trial is testing a new treatment called 177Lu-PSMA-617 for patients with prostate cancer that has spread to other parts of the body and has not responded to treatment. The treatment works
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.
Image of Massachusetts General Hospital in Boston, United States.

Enzalutamide +1 More

Androgen Receptor Inhibitor

Recruiting1 awardPhase 2
This trial aims to find a better way to treat prostate cancer that has returned after local treatment, with fewer side effects than existing treatments.
Image of Regeneron Study Site in Denver, United States.

REGN5678 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, REGN5678, to see if it is safe and effective in treating prostate cancer. The study will also look at how well the drug is tolerated and how it works in the body.
Image of VA Greater Los Angeles Healthcare System,Cancer Center Research in Los Angeles, United States.

[177Lu]Ludotadipep

Radiopharmaceutical

Recruiting2 awardsPhase 1 & 2
This trial tests the safety and effectiveness of a radioactive drug called [177Lu]Ludotadipep. The drug works by delivering radiation directly to certain cells to treat the condition. Lutetium-177 (177Lu) has been widely used in targeted therapy, particularly in peptide receptor radionuclide therapy (PRRT) for treating neuroendocrine tumors.
Image of University of Alabama at Birmingham in Birmingham, United States.

Abiraterone

Androgen Deprivation Therapy

Recruiting1 awardPhase 3
This trial is testing whether abemaciclib, when added to abiraterone plus prednisone, can help to treat prostate cancer by prolonging the time before the cancer gets worse.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.